Report: More than 600 medicines in development for diseases affecting women

As we approach the end of celebrating Women’s History Month, we’re taking a closer look at the biopharmaceutical progress made and challenges to be addressed for women’s health.
Read More
New Report: Nearly 800 new medicines in development to treat rare diseases

Today, PhRMA released a new report detailing orphan drug development in the U.S. and the potential to meet the significant unmet medical need for patients. Rare diseases and conditions individually...
Read More
Guest post: Continued research and development is critical for ALS patients and families

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
New report shows more than 260 medicines in development to fight neurodegenerative diseases

With neurodegenerative diseases affecting millions of individuals in the United States, now is an important time to spotlight the increasing impact these diseases have on our country’s aging...
Read More
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities

We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients, including...
Read More
New PhRMA report shows nearly 90 medicines in development to fight drug-resistant infections, but future pipeline remains challenging

The discovery and introduction of antibiotics in the 1940s transformed modern medicine and enabled tremendous progress in health care and life expectancy. Today, this progress is being threatened by...
Read More
Report: More than 1,300 medicines and vaccines in development to help fight cancer

Over the last 30 years, significant progress has been made in the fight against cancer. Researchers have expanded their understanding of how cancer develops and how to target medicines for specific...
Read More
New report shows nearly 260 vaccines in development, including dozens for COVID-19

Vaccines represent some of the most impactful advances in public health, helping to prevent the spread of many infectious diseases and, in many parts of the world, eliminating some of the most...
Read More
Nearly 400 cell and gene therapies in development to target a broad range of diseases

In 2017, the U.S. approved its first cell and gene therapy, making the idea of altering a gene to cure or treat a disease a reality. As the increasing pace of R&D propels cell and gene therapy...
Read More
Nearly 140 medicines in development to treat mental illness

Today is World Mental Health Day, a moment where we reflect about the challenges we still face towards better treatment of mental illness and its impact on patients.
Read More